These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 3349027
21. Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41. Holloway DE, Chavali GB, Hares MC, Baker MD, Subbarao GV, Shapiro R, Acharya KR. Biochemistry; 2004 Feb 10; 43(5):1230-41. PubMed ID: 14756559 [Abstract] [Full Text] [Related]
22. Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis. Curran TP, Shapiro R, Riordan JF. Biochemistry; 1993 Mar 09; 32(9):2307-13. PubMed ID: 8095159 [Abstract] [Full Text] [Related]
23. Dual site model for the organogenic activity of angiogenin. Hallahan TW, Shapiro R, Vallee BL. Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2222-6. PubMed ID: 2006161 [Abstract] [Full Text] [Related]
25. Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopy. Tonan K, Xu P, Jenkins JL, Russo A, Shapiro R, Ni F. Biochemistry; 2003 Sep 30; 42(38):11137-49. PubMed ID: 14503864 [Abstract] [Full Text] [Related]
26. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily. Saxena SK, Rybak SM, Davey RT, Youle RJ, Ackerman EJ. J Biol Chem; 1992 Oct 25; 267(30):21982-6. PubMed ID: 1400510 [Abstract] [Full Text] [Related]
27. RNA biology of angiogenin: Current state and perspectives. Lyons SM, Fay MM, Akiyama Y, Anderson PJ, Ivanov P. RNA Biol; 2017 Feb 25; 14(2):171-178. PubMed ID: 28010172 [Abstract] [Full Text] [Related]
28. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. Leonidas DD, Shapiro R, Allen SC, Subbarao GV, Veluraja K, Acharya KR. J Mol Biol; 1999 Jan 22; 285(3):1209-33. PubMed ID: 9918722 [Abstract] [Full Text] [Related]
30. C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin. Rybak SM, Auld DS, St Clair DK, Yao QZ, Fett JW. Biochem Biophys Res Commun; 1989 Jul 14; 162(1):535-43. PubMed ID: 2473749 [Abstract] [Full Text] [Related]
31. The amino acid sequence of human ribonuclease 4, a highly conserved ribonuclease that cleaves specifically on the 3' side of uridine. Zhou HM, Strydom DJ. Eur J Biochem; 1993 Oct 01; 217(1):401-10. PubMed ID: 8223579 [Abstract] [Full Text] [Related]
32. Conformational characterization of human angiogenin by limited proteolysis. Harper JW, Vallee BL. J Protein Chem; 1988 Aug 01; 7(4):355-63. PubMed ID: 3151251 [Abstract] [Full Text] [Related]
37. Comparison of RNases and toxins upon injection into Xenopus oocytes. Saxena SK, Rybak SM, Winkler G, Meade HM, McGray P, Youle RJ, Ackerman EJ. J Biol Chem; 1991 Nov 05; 266(31):21208-14. PubMed ID: 1939163 [Abstract] [Full Text] [Related]
38. An in vitro binding assay for angiogenin using placental ribonuclease inhibitor. Bond MD. Anal Biochem; 1988 Aug 15; 173(1):166-73. PubMed ID: 3189795 [Abstract] [Full Text] [Related]
39. Replacement of residues 8-22 of angiogenin with 7-21 of RNase A selectively affects protein synthesis inhibition and angiogenesis. Bond MD, Vallee BL. Biochemistry; 1990 Apr 03; 29(13):3341-9. PubMed ID: 1692238 [Abstract] [Full Text] [Related]
40. Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography. Leonidas DD, Chavali GB, Jardine AM, Li S, Shapiro R, Acharya KR. Protein Sci; 2001 Aug 03; 10(8):1669-76. PubMed ID: 11468363 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]